Clinical Trials Browser

Phase 1/2 × INDUSTRY × lorvotuzumab mertansine × Clear all

NCT01237678 2018-01-18

A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Phase 1/2 Terminated

181 enrolled 17 charts

Small Cell Lung Carcinoma

NCT00065429 2012-07-18

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Phase 1/2 Completed

64 enrolled 13 charts

Small Cell Lung Carcinoma